Indication
Endocarditis
10 clinical trials
18 products
Product
ExebacaseClinical trial
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of a Single Dose of Exebacase in Patients Receiving Standard-of-Care Antibiotics for the Treatment of Staphylococcus Aureus Bloodstream Infections (Bacteremia), Including Right-Sided Infective EndocarditisStatus: Terminated, Estimated PCD: 2022-09-09
Product
PlaceboClinical trial
Contribution of PET/CT With Gallium 68 Citrate (68Ga-PET/CT) for the Diagnosis of Prosthetic Valve Infective EndocarditisStatus: Not yet recruiting, Estimated PCD: 2026-02-01
Product
68Ga-citrateClinical trial
Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)Status: , Estimated PCD: 2024-10-01
Product
AmoxicillinProduct
AmpicillinClinical trial
Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia (CERT)Status: Recruiting, Estimated PCD: 2025-04-01
Product
ErtapenemClinical trial
An Oral Doxycycline Regimen to Prevent Bacteremia Following Dental ProceduresStatus: Not yet recruiting, Estimated PCD: 2025-01-15
Product
ClindamycinProduct
DoxycyclineClinical trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareStatus: Completed, Estimated PCD: 2019-11-01
Product
POPSClinical trial
Short-course Antibiotic Regimen Compared to Conventional Antibiotic Treatment for Gram-positive Cocci Infective Endocarditis: Randomized Clinical TrialStatus: Terminated, Estimated PCD: 2023-03-31
Product
AntibioticsClinical trial
Efficacy and Safety of Ampicillin and Ceftriaxone Continuous Infusion Versus Intermittent Infusion for the Treatment of Enterococcus Faecalis Infective Endocarditis (DOBLEI)Status: Not yet recruiting, Estimated PCD: 2027-07-31
Product
Experimental regimenProduct
Control regimenClinical trial
Four-week Duration Versus 6-week Duration of Therapy for the Treatment of Enterococcal EndocarditisStatus: Not yet recruiting, Estimated PCD: 2024-09-01
Clinical trial
Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk PatientsStatus: Terminated, Estimated PCD: 2012-09-01
Product
VancomycinProduct
CeftarolineProduct
DaptomycinProduct
Linezolid